Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back

Cong Wang, PhD

Qilu Hospital of Shandong University
JINAN, Shandong

Basic information


Name: Wang Cong


Age: 33 Gender: female


Title: Attending physician


Unit: Shandong University Qilu Hospital



Educational background


2021-01 ~ Now: Shandong University Pharmacy (Postdoctoral),


2013-09 ~ 2018-06: Shandong University Oncology (Doctor)


2016-08 ~ 2017-08: Oncology (Joint doctoral training), University of Toronto, Canada


2008-09 ~ 2013-07 Chongqing Medical University Clinical Medicine (Bachelor)



Work experience


2018-07-present Attending physician, Department of Tumor Radiotherapy, Qilu Hospital, Shandong University



Representative articles in the last five years



  1. Cong Wang, Jing Zhang, Hongjiao Wang, Ruixue Chen, Ming Lu. Family with sequence similarity 83, member A (FAM83A) inhibits ferroptosis via the Wnt/ß-catenin pathway in lung squamous cell cancer. Cell Death Discov. 2024 Jul 20;10(1):332.

  2. Wang C*, Yang J, Lu M. Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy. Ann Surg Oncol. 2020 Jun;27(6):2051-2060. IF:5.534

  3. Cheng B*, Wang C*, Zou B, Huang D, Yu J, Cheng Y, Meng X. A nomogram to predict outcomes of lung cancer patients after pneumonectomy based on 47 indicators. 2020 Feb;9(4):1430-1440. IF: 4.711

  4. Wang C*, Lu M*, Zhou T, Zhao S, Guan S. Intensity-modulated radiotherapy does not decrease the risk of malnutrition in esophageal cancer patients during radiotherapy compared to three-dimensional conformal radiation therapy. J Thorac Dis. 2019 Sep;11(9):3721-3731. IF:3.005

  5. Wang C*, Ding Q, Plant P, Basheer M, Yang C, Tawedrous E, Krizova A, Boulos C, Farag M, Cheng Y, Yousef GM. Droplet digital PCR improves urinary exosomal miRNA detection compared to real-time PCR. Clin Biochem. 2019 May;67:54-59. IF:3.281

Disclosures:

  • Employment: none
  • Compensation: none
  • Ownership: none
  • Leadership: none

Presentation(s):